Larvol Delta - Aura-Biosciencesannounced-it-has-completed-enrollment-of-108-patients-in-the-Phase-3-trial-evaluating-belzupacap-sarotalocan-belsar-as-a-frontline-treatment-for-patients-with-early-choroidal-melanoma

belzupacap sarotalocan (AU-011) - Aura Biosci

https://www.globenewswire.com/news-release/2026/06/01/3304295/0/en/Aura-Biosciences-Announces-Enrollment-Completion-in-Phase-3-CoMpass-Trial-of-Bel-sar-in-Early-Choroidal-Melanoma.html

Jun 1, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next